Skip to content
Research Article Open access CC BY 4.0

Lung Delivery Systems to Optimize Pharmacotherapy of COVID-19: A Concise Review

Mohsen Geza. Alrashedi, Ahmed Geza. Alrashedi, Ahmed Shaker. Ali, Ibrahim M. Ibrahim

Journal of Pharmaceutical Research International · pp. 268–277 · Published 11 Sep 2021

10.9734/jpri/2021/v33i43B32552

Abstract

Background: COVID-19 is an ongoing viral pandemic caused by the SARS-COV-2 virus. Several drugs were repurposed for its management; however, most of these drugs were not ideal treatments by traditional methods of administration, whether given by injection or orally. This is due to many reasons including pharmacokinetic limitations or drug-induced adverse effects. There is an urgent need to develop these drugs to target the virus in the lung tissue through inhalation. Objective: To address the gap in knowledge regarding efficacy and safety of pulmonary drug delivery of repurposed antiviral against COVID-19. Findings: Ongoing trials for inhalable formulations of several drugs such as Niclosamide; Remdesivir, Hydroxychloroquine, and Azithromycin among others showed promising results. Conclusion: The development of pharmaceutical forms for inhaled administration of antiviral and anti-inflammatory drugs is an important direction that needs more attention to achieve the optimal management of respiratory infectious diseases.

COVID-19 antiviral drugs pulmonary drug delivery aerosol niclosamide remdesivir hydroxychloroquine azithromycin

Cited by 3

Local Delivery of Azithromycin Nanoformulation Attenuated Acute Lung Injury in Mice

Mohsen G. Alrashedi, Ahmed Shaker Ali, Osama Abdelhakim Ahmed · Molecules · 2022

Progress on Thin Film Freezing Technology for Dry Powder Inhalation Formulations

Sagar R. Pardeshi, Eknath B. Kole, Harshad S. Kapare · Pharmaceutics · 2022

Pulmonary Delivery of Hydroxychloroquine Nanostructured Lipid Carrier as a Potential Treatment of COVID-19

Ahmed Shaker Ali, Mohsen Geza Alrashedi, Osama Abdelhakim Aly Ahmed · Polymers · 2022

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

3

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.